Results 101 to 110 of about 14,798 (236)

Nicotiana benthamiana as a Source of Cowpea Mosaic Virus‐Derived Particles That Specifically Package Designer RNAs

open access: yesPlant Biotechnology Journal, Volume 24, Issue 1, Page 159-170, January 2026.
ABSTRACT The coupling of replication and encapsidation in the bipartite plant virus, cowpea mosaic virus (CPMV), has been used to specifically incorporate designer RNA molecules into viral particles via transient expression in Nicotiana benthamiana. This is achieved by placing the desired RNA sequence between the 5′ and 3′ UTRs of CPMV RNA‐2 so that ...
H. Peyret   +5 more
wiley   +1 more source

Evaluation of medicinal herbs for Anti-CHIKV activity.

open access: yesVirology, 2019
Chikungunya, a mosquito-borne viral disease is now a global public health problem. In tropical countries such as India, periodic chikungunya outbreaks can occur due the high prevalence of the mosquito vector, circulation of virus and the high population density.
Siva, Raghavendhar   +3 more
openaire   +2 more sources

Antiviral activity of silymarin against chikungunya virus [PDF]

open access: yes, 2015
Citation: Lani, R., Hassandarvish, P., Chiam, C. W., Moghaddam, E., Chu, J. J. H., Rausalu, K., . . . Zandi, K. (2015). Antiviral activity of silymarin against chikungunya virus. Scientific Reports, 5, 10.
Abu Bakar, S.   +10 more
core   +1 more source

Blood donor West Nile virus screening identifies three autochthonous Usutu virus infections in Spain

open access: yesTransfusion, Volume 66, Issue 1, Page 56-62, January 2026.
Abstract Background Considering the increase of West Nile virus (WNV) circulation in Europe, blood banks perform WNV Nucleic Acid Test testing to ensure transfusion safety during the WNV transmission season. Usutu virus (USUV), an arbovirus related to WNV, has relevant molecular and serological cross‐reactivity with WNV. Study Design and Methods During
Teresa Jimenez‐Marco   +14 more
wiley   +1 more source

Chikungunya virus (CHIKV) infection: Analytical performance of real-time NASBA assay [PDF]

open access: yesInternational Journal of Infectious Diseases, 2010
n ...
G. Rossini   +5 more
openaire   +2 more sources

Human Convalescent Serum Sample after CHIKV and DENV seroconversion.

open access: green, 2018
Brett E Pickett   +3 more
  +6 more sources

Characterizing the Bacterial Microbiome of the Invasive Vector Aedes albopictus in Hungary: A Pilot Study Using Oxford Nanopore Sequencing

open access: yesInternational Journal of Microbiology, Volume 2026, Issue 1, 2026.
Aedes albopictus has recently established self‐sustaining populations in Hungary, but its microbiota—which may influence vector competence—remains poorly understood. We used Oxford Nanopore long‐read sequencing for full‐length 16S rRNA gene profiling of adult Ae. albopictus from two urban sites, Pécs and Barcs.
Kornélia Kurucz   +9 more
wiley   +1 more source

Mathematical analysis and control of chikungunya (CHIKV) virus by SEIR model

open access: yesInternational journal of health sciences, 2022
Chikungunya is a re-emerging arboviral disease in Asia and Africa infected by Aedes mosquitoes which had posed a global threat in several countries. Vector borne diseases are the primary cause of death in most of the world countries, hence it becomes pertinent to control these vector borne diseases.
Seema Singla, Madhuchanda Rakshit
openaire   +1 more source

Chikungunya virus entry is strongly inhibited by phospholipase A2 isolated from the venom of Crotalus durissus terrificus

open access: yesScientific Reports, 2021
Chikungunya virus (CHIKV) is the etiologic agent of Chikungunya fever, a globally spreading mosquito-borne disease. There is no approved antiviral or vaccine against CHIKV, highlighting an urgent need for novel therapies.
Igor Andrade Santos   +12 more
doaj   +1 more source

Therapeutic Antibodies for Mosquito‐Borne Orthoflavivirus Infections: Discovery, Engineering Approaches, and Advances in mRNA‐Based Delivery Systems

open access: yesAdvanced Therapeutics, Volume 8, Issue 12, December 2025.
This review explores how antibody engineering and display technologies are driving therapeutic advances against mosquito‐borne orthoflaviviruses such as Zika, dengue, and yellow fever viruses. It highlights diverse neutralizing targets on the envelope protein, including the conserved fusion loop, and discusses how Fc engineering, rational antigen ...
Ana Clara Barbosa Antonelli   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy